Dissecting IWG-2 typical and atypical Alzheimer’s disease: insights from cerebrospinal fluid analysis

Early-Versus Late-Onset Alzheimer's Disease: More than Age Alone

(2017) Esther L.G.E. Koedam et al.   JOURNAL OF ALZHEIMERS DISEASE

The cerebrospinal fluid “Alzheimer profile”: Easily said, but what does it mean?

(2014) Flora H. Duits et al.   Alzheimers & Dementia

Tau, amyloid, and hypometabolism in a patient with posterior cortical atrophy

(2014) Rik Ossenkoppele et al.   ANNALS OF NEUROLOGY

Cerebrospinal Fluid Biomarkers in Clinical Subtypes of Early-Onset Alzheimer's Disease

(2014) Edmond Teng et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria

(2014) Bruno Dubois et al.   LANCET NEUROLOGY

Further evidence about the crucial role of CSF biomarkers in diagnosis of posterior cortical atrophy

(2014) E. Coppi et al.   NEUROLOGICAL SCIENCES

CSF neurofilament light differs in neurodegenerative diseases and predicts severity and survival

(2014) T. Skillback et al.   NEUROLOGY

Late-onset Alzheimer disease genetic variants in posterior cortical atrophy and posterior AD

(2014) M. M. Carrasquillo et al.   NEUROLOGY

Accuracy of Brain Amyloid Detection in Clinical Practice Using Cerebrospinal Fluid β-Amyloid 42

(2014) Sebastian Palmqvist et al.   JAMA Neurology

Cerebrospinal fluid neurofilament concentration reflects disease severity in frontotemporal degeneration

(2013) Carole S. Scherling et al.   ANNALS OF NEUROLOGY

Inflammation in Alzheimer’s disease: insights from immunotherapy

(2013) Jonathan M. Schott et al.   BRAIN

Diverging patterns of amyloid deposition and hypometabolism in clinical variants of probable Alzheimer’s disease

(2013) Manja Lehmann et al.   BRAIN

Soluble amyloid precursor protein α and β in CSF in Alzheimer's disease

(2013) Gunnar Brinkmalm et al.   BRAIN RESEARCH

Biomarker Modelling of Early Molecular Changes in Alzheimer’s Disease

(2013) Ross W. Paterson et al.   Molecular Diagnosis & Therapy

Fluid biomarkers in Alzheimer’s disease – current concepts

(2013) Christoffer Rosén et al.   Molecular Neurodegeneration

FDG PET and MRI in Logopenic Primary Progressive Aphasia versus Dementia of the Alzheimer’s Type

(2013) Ajay Madhavan et al.   PLoS One

Posterior cortical atrophy

(2012) Sebastian J Crutch et al.   LANCET NEUROLOGY

Similar amyloid-β burden in posterior cortical atrophy and Alzheimer's disease

(2011) Leonardo Cruz de Souza et al.   BRAIN

Subtypes of progressive aphasia: application of the international consensus criteria and validation using β-amyloid imaging

(2011) Cristian E. Leyton et al.   BRAIN

In vivo demonstration of amyloid burden in posterior cortical atrophy: a case series with PET and CSF findings

(2011) Maïté Formaglio et al.   JOURNAL OF NEUROLOGY

CSF biomarkers in posterior cortical atrophy

(2011) J. Seguin et al.   NEUROLOGY

Distinct clinical and metabolic deficits in PCA and AD are not related to amyloid distribution

(2011) M. H. Rosenbloom et al.   NEUROLOGY

Classification of primary progressive aphasia and its variants

(2011) M. L. Gorno-Tempini et al.   NEUROLOGY

YKL-40: A Novel Prognostic Fluid Biomarker for Preclinical Alzheimer's Disease

(2010) Rebecca Craig-Schapiro et al.   BIOLOGICAL PSYCHIATRY

CSF-Tau and CSF-Aβ1–42 in Posterior Cortical Atrophy

(2010) Thomas P. Baumann et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

Relation between frontal lobe symptoms and dementia severity within and across diagnostic dementia categories

(2010) Marcel J. H. Aries et al.   INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY

The diagnosis of young-onset dementia

(2010) Martin N Rossor et al.   LANCET NEUROLOGY

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

(2010) Kaj Blennow et al.   Nature Reviews Neurology

Cerebrospinal fluid amyloid β40is decreased in cerebral amyloid angiopathy

(2009) Marcel M. Verbeek et al.   ANNALS OF NEUROLOGY

Total and phosphorylated tau protein as biological markers of Alzheimer’s disease

(2009) Harald Hampel et al.   EXPERIMENTAL GERONTOLOGY

Amyloid β peptides in plasma in early diagnosis of Alzheimer's disease: A multicenter study with multiplexing

(2009) P. Lewczuk et al.   EXPERIMENTAL NEUROLOGY

Differentiating the frontal variant of Alzheimer's disease

(2009) Michael Woodward et al.   INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY

Combined CSF tau, p-tau181 and amyloid-β 38/40/42 for diagnosing Alzheimer’s disease

(2009) Volker Welge et al.   JOURNAL OF NEURAL TRANSMISSION

Cortical thickness and voxel-based morphometry in posterior cortical atrophy and typical Alzheimer's disease

(2009) Manja Lehmann et al.   NEUROBIOLOGY OF AGING

Combined rCBF and CSF biomarkers predict progression from mild cognitive impairment to Alzheimer's disease

(2007) Oskar Hansson et al.   NEUROBIOLOGY OF AGING